Technology News and Research

RSS

Radiomics significantly outperforms clinical models for predicting NPC treatment outcome

Nasopharyngeal carcinoma (NPC) is a highly aggressive malignancy, with most patients presenting at locally advanced stages. While immune checkpoint inhibitors, such as PD-1 blockade, have reshaped treatment strategies, only a minority of patients achieve durable benefit. Accurate biomarkers for predicting treatment response remain an urgent unmet need.

30 Sep 2025

Tissue-mimicking hydrogels drive cell reprogramming via matrix remodeling

The mechanical properties of tissue matrix are crucial for maintaining cell health and function. With aging, tissue matrix loses its mechanical integrity and exhibits altered biophysical properties, which are closely associated with various diseases including neurodegenerative diseases and cancers.

30 Sep 2025

Myo-inositol fails to lower pregnancy risks in women with PCOS

Myo-inositol supplementation shows no significant benefits in preventing pregnancy complications for women with PCOS, according to a recent large-scale study.

30 Sep 2025

Five-session SBRT reduces side effects in intermediate-risk prostate cancer

For patients with intermediate-risk, localized prostate cancer, radiation therapy delivered in five sessions reduced patient-reported side effects compared to longer courses of radiation, according to results of a large, randomized phase III trial.

29 Sep 2025

Proton therapy and IMRT show similar outcomes in head and neck cancer trial

A new phase III clinical trial finds that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in similar quality-of-life outcomes and low rates of side effects for people with locally advanced oropharyngeal cancer.

29 Sep 2025

New combination drug therapy offers hope for treating chronic wound infections

University of Oregon researchers have tested a new combination drug therapy that could dismantle the difficult-to-treat bacteria inhabiting chronic wound infections.

29 Sep 2025

Cornell launches new initiative to uncover how menopause shapes health and disease

Two centuries ago, few women lived long enough to reach menopause. Today, it marks a major inflection point in women's health, yet remains poorly understood. Cornell researchers aim to change that.

29 Sep 2025

Study points toward earlier and more accurate detection of ALS

A new study applying multi-omics techniques and machine learning identified 33 plasma proteins that differ significantly in patients with amyotrophic lateral sclerosis (ALS).

29 Sep 2025

New mRNA vaccine stops allergens from causing life-threatening inflammation in mice

A new mRNA vaccine stopped allergens from causing dangerous immune reactions and life-threatening inflammation in mice, according to researchers from the Perelman School of Medicine at the University of Pennsylvania and Cincinnati Children's.

29 Sep 2025

Cancer cell nuclear hypertrophy can suppress metastasis

In tissue biopsies, cancer cells are frequently observed to have nuclei (the cell's genetic information storage) larger than normal.

29 Sep 2025

Novel biosensing platform provides quantitative graded evaluation of mild to severe liver injury

Real-time monitoring of key biomarkers is a critical prerequisite for early disease diagnosis and personalized therapy. Early detection of liver function impairment particularly relies on the measurement of serum alanine aminotransferase (ALT).

29 Sep 2025

Super-resolution imaging unlocks the role of transporter nanoclusters in tumor metabolism

Serine serves as a metabolic nexus in tumors, coordinating one-carbon metabolism, nucleotide synthesis, and redox regulation. In recent years, targeting the serine metabolic pathway, particularly the rate-limiting enzyme PHGDH, has attracted considerable attention as a promising anticancer strategy.

29 Sep 2025

Ligolab and Pathpresenter announce strategic partnership to deliver seamless digital pathology workflows

LigoLab, a leading provider of enterprise laboratory information system (LIS) software and fully integrated laboratory revenue cycle management (lab RCM) solutions, and PathPresenter, a global leader in digital pathology image viewing and management solutions, today announced a strategic partnership.

From PathPresenter 27 Sep 2025

Engineers create designer biobots using human lung cells

A brand-new engineering approach to generate "designer" biological robots using human lung cells is underway in Carnegie Mellon University's Ren lab.

26 Sep 2025

Study reveals long-term effects of hyaluronic acid fillers

Initial and follow-up 3D digital scans provide new insights into the effects of hyaluronic acid (HA) fillers in restoring facial volume and fullness, reports a study in the October issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons.

26 Sep 2025

Novel treatment disrupts tumor immunosuppression in pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a five-year survival rate below 10%.

26 Sep 2025

IGF2BP3 protein drives leukemia growth by linking metabolism and RNA control

Cancer cells are relentless in their quest to grow and divide, often rewiring their metabolism and modifying RNA to stay one step ahead.

26 Sep 2025

New intramuscular mRNA vaccine offers easier alternative to treat neovascular eye diseases

An mRNA vaccine developed by researchers from Japan suppressed abnormal blood vessel growth or neovascularization in the retina of mouse models.

26 Sep 2025

Optogenetics and artificial intelligence open path to personalized Parkinson’s treatment

Globally recognized figures like Muhammad Ali and Michael J. Fox have long suffered from Parkinson's disease. The disease presents a complex set of motor symptoms, including tremors, rigidity, bradykinesia, and postural instability.

26 Sep 2025

Tumor cells adapt and thrive in damaged parts of the pancreas

Pancreatic cancer is one of the most aggressive cancer types. A new study from Karolinska Institutet, in collaboration with the Department of Pathology at Karolinska University Hospital, shows that tumor cells grow not only in the connective tissue-rich environment typical of the disease, but also in damaged parts of the pancreas where normal tissue is altered.

26 Sep 2025

Technology News and Research

Radiomics significantly outperforms clinical models for predicting NPC treatment outcome

Tissue-mimicking hydrogels drive cell reprogramming via matrix remodeling

Myo-inositol fails to lower pregnancy risks in women with PCOS

Five-session SBRT reduces side effects in intermediate-risk prostate cancer

Proton therapy and IMRT show similar outcomes in head and neck cancer trial

New combination drug therapy offers hope for treating chronic wound infections

Cornell launches new initiative to uncover how menopause shapes health and disease

Study points toward earlier and more accurate detection of ALS

New mRNA vaccine stops allergens from causing life-threatening inflammation in mice

Cancer cell nuclear hypertrophy can suppress metastasis

Novel biosensing platform provides quantitative graded evaluation of mild to severe liver injury

Super-resolution imaging unlocks the role of transporter nanoclusters in tumor metabolism

Ligolab and Pathpresenter announce strategic partnership to deliver seamless digital pathology workflows

Engineers create designer biobots using human lung cells

Study reveals long-term effects of hyaluronic acid fillers

Novel treatment disrupts tumor immunosuppression in pancreatic cancer

IGF2BP3 protein drives leukemia growth by linking metabolism and RNA control

New intramuscular mRNA vaccine offers easier alternative to treat neovascular eye diseases

Optogenetics and artificial intelligence open path to personalized Parkinson’s treatment

Tumor cells adapt and thrive in damaged parts of the pancreas

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News